April 2013
Regeneron Pharmaceuticals, Biogen Idec and Vertex Pharmaceuticals were up on positive news flow. Following several months of strong performance, Infinity’s stock retreated due in part to a large block sale from a prior collaborator, Purdue Pharma.
Read More…
Latest Fact Sheet
Latest Annual or Interim Report
To request emailed copies of monthly fact sheets and other relevant information, please register below.